MYOC Glaucoma
DEDICATED TO DISCOVERING THE CAUSES AND THE CURES FOR GLAUCOMA
LAB NEWS
Dr. Fingert is named a Carver College of Medicine Impact Scholar
The Carver College of Medicine recognizes faculty whose work has significantly influenced their research field (measured by a Hirsch-index ≥ 50) with an IMPACT SCHOLAR AWARD.
​
Dr. Fingert was recognized as a Silver Impact Scholar at a ceremony in the MERF building on April 28, 2025.
Read more about the CCOM Impact Scholar awards here.
OUR MAJOR PROJECTS
TBK1 GENE
AND NORMAL TENSION GLAUCOMA
We discovered that TBK1 gene duplications or triplications are one of the most common known causes of normal tension glaucoma. We continue to study how mutations in TBK1 cause glaucoma using human donor eyes, stem cell biology, and transgenic animals. Read more about this research here.
OUR PUBLICATIONS
Click here to see all of our publications on PUBMED
Select publications described below:
OUR MAJOR DISCOVERIES
• Discovery of the first glaucoma gene (MYOC)
• Discovery of a low pressure glaucoma gene (TBK1)
• Engineering transgenic mice that develop low pressure glaucoma due to TBK1 gene mutation
• Creating induced pluripotent stem cells (iPSCs) with TBK1 mutations
• First genetic studies of Ocular Hypertension Treatment Study (OHTS)​
• First Exome study of Pigmentary Glaucoma